New drug for Duchenne muscular dystrophy clears phase 1 clinical trial testing in boys
Friday, February 22, 2019 - 09:00
in Health & Medicine
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.